Citable company snapshot
Elevance Health's latest SEC-sourced 2026-03-31 period shows $50.18B in revenue and $1.76B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:Revenues | Mar 31, 2026 | $50.18B | $49.75B | +0.9% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $2.09B | $309.00M | +575.1% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $1.76B | $547.00M | +222.5% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $4.33B | $84.00M | +5057.1% |
| Free Cash Flow (computed) | Mar 31, 2026 | $4.10B | $-209.00M | +2060.3% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed Apr 22, 2026; accession 0001156039-26-000043.
Continue research
Follow same-sector companies and source explainers connected to the overview view.
A factual guide to market capitalization, shares outstanding, public float, and why share-count definitions matter.
A factual guide to dividends, share repurchases, and how companies can return capital to shareholders.
A factual guide to book value, tangible book value, and balance-sheet net worth measures.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.